Prudential Financial’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.4M | Buy |
598,900
+5,705
| +1% | +$80K | 0.01% | 703 |
|
|
2025
Q1 | $9.28M | Buy |
593,195
+630
| +0.1% | +$9.85K | 0.01% | 612 |
|
|
2024
Q4 | $8.25M | Buy |
592,565
+19,950
| +3% | +$278K | 0.01% | 686 |
|
|
2024
Q3 | $5.33M | Hold |
572,615
| – | – | 0.01% | 970 |
|
|
2024
Q2 | $5.33M | Sell |
572,615
-150,710
| -21% | -$1.4M | 0.01% | 895 |
|
|
2024
Q1 | $7.17M | Sell |
723,325
-94,730
| -12% | -$939K | 0.01% | 784 |
|
|
2023
Q4 | $2.64M | Buy |
818,055
+454,640
| +125% | +$1.47M | ﹤0.01% | 1266 |
|
|
2023
Q3 | $2.01M | Hold |
363,415
| – | – | ﹤0.01% | 1364 |
|
|
2023
Q2 | $3.46M | Buy |
363,415
+200,585
| +123% | +$1.91M | 0.01% | 1095 |
|
|
2023
Q1 | $1.79M | Buy |
162,830
+65,975
| +68% | +$726K | ﹤0.01% | 1409 |
|
|
2022
Q4 | $1.43M | Buy |
96,855
+30,020
| +45% | +$444K | ﹤0.01% | 1510 |
|
|
2022
Q3 | $1.28M | Buy |
66,835
+340
| +0.5% | +$6.5K | ﹤0.01% | 1619 |
|
|
2022
Q2 | $1.42M | Buy |
+66,495
| New | +$1.42M | ﹤0.01% | 1592 |
|